Namibia had a prevalence of HIV infection of 17.2% in 2016. That rate of infection, coupled with the vastness of the country and a shortage of qualified pharmaceutical personnel, resulted in a critical need to strengthen health systems. Below are some highlights of SIAPS’ ongoing work in the country. Ensuring access to safe and quality […]
Archive | HIV and AIDSRSS feed for this section
A Q&A with Greatjoy Mazibuko, SIAPS Senior Technical Manager in Namibia You’re working in Namibia, which has one of the highest prevalence rates of HIV in the world. How does this affect life in the country? The prevalence of HIV infection stood at 17.2% in 2016, which is relatively high for sub-Saharan Africa, but it’s […]
The approval of TDF/FTC (trade name Truvada®) by the Namibian Medicines Regulatory Council (NMRC) on May 11, 2017, brings renewed hope for achieving an AIDS-free generation in Namibia. The availability and use of TDF/FTC for pre-exposure prophylaxis (PrEP) for adults at high risk of sexually acquired HIV-1 in Namibia could significantly reduce the emergence of […]
On June 1, 2017, 38 new pharmacy assistants (PAs) graduated from Namibia’s National Health Training Center (NHTC). At the graduation ceremony, Dr. Andreas Mwoombola, the Permanent Secretary of the Ministry of Health and Social Services (MOHSS), encouraged the graduates to prioritize the health of their communities and to serve those communities with dignity. He decried […]
Patients on lifelong antiretroviral therapy (ART) may be at risk of forgetting their pharmacy appointments for antiretroviral (ARV) refills. The SMS-based ART pharmacy appointment and medication adherence reminder service provides automated text notifications to ART patients reminding them to pick up their ARV refills according to appointment dates made by pharmacy staff using the SIAPS-supported Electronic Dispensing Tool (EDT). The service was introduced in May 2015 at 10 public-sector ART sites in 6 of Namibia’s 14 regions.
The West Africa Regional HIV Pharmaceutical Management Information Dashboard is developed and implemented for fifteen focus West African countries for better management of HIV and AIDS commodities. The goal of the Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard will assist focus countries and subregional organizations in improving forecasting, supply planning, and procurement to support the continuous availability of ARVs, RTKs, and other HIV- and AIDS-related commodities.
The goal of the OSPSIDA Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard offers regional partners a platform through which they may easily share information on funding flows and stock-out risks. The data available on this platform will be used to inform decision making and assist in identifying solutions to mitigate risks in the short-, medium-, and long-term. This User Guide assists users to make entries into the OSPSIDA Dashboard smoothly. The user guide has step-by-step guidance on how to access the dashboard, enter information, and generate reports.
SIAPS supported the Swaziland Ministry of Health (MOH) in mobilizing key stakeholders from the Swaziland National AIDS Program and the National Tuberculosis Control Program to introduce and implement an active surveillance system for patients on ARVs and anti-TB treatment. SIAPS provided technical assistance to MOH’s National Pharmacovigilance Unit (NPVU) to develop the protocol and tools to implement the system, as well as to develop a system for recruiting patients at the HIV and TB sites.
Manuel de procédures de gestion des achats et des stocks des produits de santé de lutte contre le VIH/SIDA
Ce manuel de procédures de Gestion des Achats et des Stocks (GAS) des produits de lutte contre le VIH/Sida vise à décrire d’une manière synthétique les procédures à suivre par le GTC-CNLS, la Centrale Nationale d’Approvisionnement en Médicaments et consommables médicaux Essentiels (CENAME), les Centres d’Approvisionnement Pharmaceutique Régionaux (CAPR) et les Formations Sanitaires (FOSA) lors des activités liées à la gestion des achats et des stocks des produits de santé de lutte contre le VIH/Sida acquis dans le cadre de la subvention de la série 10 du Fonds mondial de Lutte contre le VIH/SIDA, la Tuberculose et le Paludisme.
Compiled by Wezi Tjaronda (SIAPS), Samson Mwinga (SIAPS), Harriet Kagoya (SIAPS), and Greatjoy Mazibuko (SIAPS) At the Kaisosi settlement in Rundu, Namibia, antiretroviral therapy (ART) patients who were once lost to follow up (LTFU) are returning for care. One of these patients, Domingos Christophine*, a 39-year-old single mother, began ART at the Kuisebmund clinic in […]